Pharmaceuticals: Global Industry Guide
Pages: 180
Publisher: Datamonitor
Date Published: January 2006
Format: PDF
Price: $995
Overview
Datamonitor’s Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
- Contains an executive summary and data on value and segmentation
- Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
- Covers Global, European, Asia-Pacific & 11 individual country markets
- Includes a five-year forecast of the industry
Highlights
The global pharmaceuticals market has demonstrated consistently strong growth patterns in the last five years.
The leading revenue source for the global pharmaceuticals market is the sale of cardiovascular drugs.
The last five years have produced turbulent times for big pharmaceutical firms. Blockbuster drug patent expirations and subsequent competition from pharmaceutical generics have been detrimental to market growth.
Why you should buy this report:
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Definition
The global pharmaceuticals market has demonstrated consistently strong growth patterns in the last five years. Market expansion was buoyed up by continued good growth in the US.
The global pharmaceuticals market generated total revenues of $534.8 billion in 2005, this representing a compound annual growth rate (CAGR) of 7.7% for the five-year period spanning 2001-2005. In comparison, the European pharmaceuticals market generated total revenues of $150.5 billion in 2005, this equates to a CAGR of 6% for the same period, while the US market had a value of $285.6 billion in 2005, having grown with a CAGR of nearly 10% during the 2001-2005 period.
The leading revenue source for the global pharmaceuticals market is the sale of cardiovascular drugs, which generated total revenues of $107.2 billion in 2005, equivalent to 20% of the overall market value. In comparison, the central nervous system sector was worth $91.1 billion, which represented a 17% share of the market’s value.
Looking forward, the market is forecast to decelerate its current performance slightly, with an anticipated CAGR of 7.5% for the period 2005-2010 expected to drive the market to a value of $767.2 billion by the end of 2010. In comparison, the European market is also expected to decelerate its current performance, with an anticipated CAGR of 5.5% expected to drive the market to a value of $196.5 billion by 2010.
Table of Contents
TABLE OF CONTENTS
CHAPTER 1 Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
CHAPTER 2 Global Pharmaceuticals
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
CHAPTER 3 Pharmaceuticals in Asia-Pacific
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
CHAPTER 4 Pharmaceuticals in Europe
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 5 Pharmaceuticals in Belgium
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 6 Pharmaceuticals in Canada
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 7 Pharmaceuticals in China
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 8 Pharmaceuticals in France
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 9 Pharmaceuticals in Germany
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 10 Pharmaceuticals in Italy
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 11 Pharmaceuticals in Japan
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 12 Pharmaceuticals in Spain
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 13 Pharmaceuticals in the Netherlands
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 14 Pharmaceuticals in the United Kingdom
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 15 Pharmaceuticals in the United States
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Competitive Landscape
Market Forecasts
Macroeconomic Indicators
CHAPTER 16 Company Profiles
AstraZeneca PLC
Sanofi-Aventis Group
Pfizer Inc
GlaxoSmithKline Plc
Merck & Co. Inc.
CHAPTER 17 Appendix
Research methodology
Report writing team
LIST OF TABLES
Table 1: Global Pharmaceuticals Market Value: $ billion, 2001-2005
Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 4: Global Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 5: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2001-2005
Table 6: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 7: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 8: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 9: Europe Pharmaceuticals Market Value: $ billion, 2001-2005
Table 10: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 11: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 12: Europe Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 13: Europe Exchange Rate, 2001
Table 14: Belgium Pharmaceuticals Market Value: $ billion, 2001-2005
Table 15: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 16: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 17: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 18: Belgium Size of Population (million) , 2001-2005
Table 19: Belgium GDP (1995=100), 2001-2005
Table 20: Belgium Inflation, 2001-2005
Table 21: Belgium Exchange Rate, 2001
Table 22: Canada Pharmaceuticals Market Value: $ billion, 2001-2005
Table 23: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 24: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 25: Canada Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 26: Canada Size of Population (million) , 2001-2005
Table 27: Canada GDP (1995=100), 2001-2005
Table 28: Canada Inflation, 2001-2005
Table 29: Canada Exchange Rate, 2001
Table 30: China Pharmaceuticals Market Value: $ billion, 2001-2005
Table 31: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 32: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 33: China Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 34: China Size of Population (million) , 2001-2005
Table 35: China GDP (1995=100), 2001-2005
Table 36: China Inflation, 2001-2005
Table 37: China Exchange Rate, 2001
Table 38: France Pharmaceuticals Market Value: $ billion, 2001-2005
Table 39: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 40: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 41: France Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 42: France Size of Population (million) , 2001-2005
Table 43: France GDP (1995=100), 2001-2005
Table 44: France Inflation, 2001-2005
Table 45: France Exchange Rate, 2001
Table 46: Germany Pharmaceuticals Market Value: $ billion, 2001-2005
Table 47: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 48: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 49: Germany Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 50: Germany Size of Population (million) , 2001-2005
Table 51: Germany GDP (1995=100), 2001-2005
Table 52: Germany Inflation, 2001-2005
Table 53: Germany Exchange Rate, 2001
Table 54: Italy Pharmaceuticals Market Value: $ billion, 2001-2005
Table 55: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 56: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 57: Italy Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 58: Italy Size of Population (million) , 2001-2005
Table 59: Italy GDP (1995=100), 2001-2005
Table 60: Italy Inflation, 2001-2005
Table 61: Italy Exchange Rate, 2001
Table 62: Japan Pharmaceuticals Market Value: $ billion, 2001-2005
Table 63: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 64: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 65: Japan Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 66: Japan Size of Population (million) , 2001-2005
Table 67: Japan GDP (1995=100), 2001-2005
Table 68: Japan Exchange Rate, 2001
Table 69: Spain Pharmaceuticals Market Value: $ billion, 2001-2005
Table 70: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 71: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 72: Spain Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 73: Spain Size of Population (million) , 2001-2005
Table 74: Spain GDP (1995=100), 2001-2005
Table 75: Spain Inflation, 2001-2005
Table 76: Spain Exchange Rate, 2001
Table 77: Netherlands Pharmaceuticals Market Value: $ billion, 2001-2005
Table 78: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 79: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 80: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 81: Netherlands Size of Population (million) , 2001-2005
Table 82: Netherlands GDP (1995=100), 2001-2005
Table 83: Netherlands Inflation, 2001-2005
Table 84: Netherlands Exchange Rate, 2001
Table 85: United Kingdom Pharmaceuticals Market Value: $ billion, 2001-2005
Table 86: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 87: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 88: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 89: United Kingdom Size of Population (million) , 2001-2005
Table 90: United Kingdom GDP (1995=100), 2001-2005
Table 91: United Kingdom Inflation, 2001-2005
Table 92: United Kingdom Exchange Rate, 2001
Table 93: United States Pharmaceuticals Market Value: $ billion, 2001-2005
Table 94: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Table 95: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Table 96: United States Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Table 97: United States Size of Population (million) , 2001-2005
Table 98: United States GDP (1995=100), 2001-2005
Table 99: United States Inflation, 2001-2005
Table 100: AstraZeneca PLC Key Facts
Table 101: AstraZeneca PLC SWOT Analysis
Table 102: Sanofi-Aventis Group Key Facts
Table 103: Sanofi-Aventis Group SWOT Analysis
Table 104: Pfizer Inc Key Facts
Table 105: Pfizer Inc SWOT Analysis
Table 106: GlaxoSmithKline Plc Key Facts
Table 107: GlaxoSmithKline Plc SWOT Analysis
Table 108: Merck & Co. Inc. Key Facts
Table 109: Merck & Co. Inc. SWOT Analysis
LIST OF FIGURES
Figure 1: Global Pharmaceuticals Market Value: $ billion, 2001-2005
Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Figure 4: Global Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Figure 5: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2001-2005
Figure 6: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Figure 7: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Figure 8: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Figure 9: Europe Pharmaceuticals Market Value: $ billion, 2001-2005
Figure 10: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Figure 11: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
Figure 12: Europe Pharmaceuticals Market Value Forecast: $ billion, 2005-2010
Figure 13: Belgium Pharmaceuticals Market Value: $ billion, 2001-2005
Figure 14: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2005
Figure 15: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2005
